SkinHealth Systems (SKIN) Non-Current Deffered Revenue (2020 - 2021)
SkinHealth Systems' (SKIN) quarterly Non-Current Deffered Revenue came in at $16.1 million in Q1 2021, little changed quarter-over-quarter from $16.1 million in Q4 2020.
Powered by 
Analysis
SkinHealth Systems (SKIN) Non-Current Deffered Revenue (2020 - 2021) Analysis & Trends
SkinHealth Systems (SKIN) has reported Non-Current Deffered Revenue for 2 consecutive years, with $16.1 million the latest figure, recorded in Q1 2021.
- On a quarterly basis, Non-Current Deffered Revenue changed N/A year-over-year to $16.1 million in Q1 2021; TTM through Mar 2021 was $16.1 million, a N/A change from a year earlier, with the FY2020 full-year figure at $16.1 million, changed N/A from the prior year.
- Non-Current Deffered Revenue was $16.1 million for Q1 2021 at SkinHealth Systems, roughly flat from $16.1 million in the prior quarter.
- Over five years, Non-Current Deffered Revenue peaked at $16.1 million in Q4 2020 and troughed at $16.1 million in Q4 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | - |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | - |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | - |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | - |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | - |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | - |
| 10 | SkinHealth Systems | 89.77 Mn | -116.30 Mn | 49.34 Mn | - |